80 related articles for article (PubMed ID: 10443830)
1. Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum.
Jordan JA; Schwade ND; Truelson JM
Laryngoscope; 1999 Aug; 109(8):1259-62. PubMed ID: 10443830
[TBL] [Abstract][Full Text] [Related]
2. In vivo interaction of cis-platinum and fosfomycin on squamous cell carcinoma.
Tandy JR; Tandy RD; Farris P; Truelson JM
Laryngoscope; 2000 Jul; 110(7):1222-4. PubMed ID: 10892700
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of cisplatin-induced ototoxicity by fosfomycin.
Schweitzer VG; Dolan DF; Abrams GE; Davidson T; Snyder R
Laryngoscope; 1986 Sep; 96(9 Pt 1):948-58. PubMed ID: 3747696
[TBL] [Abstract][Full Text] [Related]
4. Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.
Knecht R; Peters S; Adunka O; Strebhardt K; Gstoettner W; Hambek M
Anticancer Res; 2003; 23(3B):2577-83. PubMed ID: 12894544
[TBL] [Abstract][Full Text] [Related]
5. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
6. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
7. [Reduction of cisplatin toxicity by fosfomycin in animal models].
Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
Gan To Kagaku Ryoho; 1984 Nov; 11(11):2400-7. PubMed ID: 6541892
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic efficacy of fosfomycin and cisplatin alone or in combination on human urogenital cancer by subrenal capsule assay].
Murahashi I; Hosoya Y; Mukae K; Honda M; Takasaki E
Gan To Kagaku Ryoho; 1991 Feb; 18(2):211-4. PubMed ID: 1992914
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
Scher RL
Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613
[TBL] [Abstract][Full Text] [Related]
10. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
[TBL] [Abstract][Full Text] [Related]
11. Extract of Prunus persica flesh (PPFE) improves chemotherapeutic efficacy and protects against nephrotoxicity in cisplatin-treated mice.
Lee CK; Park KK; Hwang JK; Lee SK; Chung WY
Phytother Res; 2009 Jul; 23(7):999-1005. PubMed ID: 19140122
[TBL] [Abstract][Full Text] [Related]
12. [Influence of a fosfomycin combination on the anti-tumor effect of CDDP].
Sagara N; Nakano K; Aizawa M; Hara S; Inufusa H; Mori N; Kurooka K; Haeno Y; Yasutomi M
Gan To Kagaku Ryoho; 1988 Jan; 15(1):97-100. PubMed ID: 3337531
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction of cisplatin and fosfomycin on squamous cell carcinoma cultures.
Olson JJ; Truelson JM; Street N
Arch Otolaryngol Head Neck Surg; 1994 Nov; 120(11):1253-7. PubMed ID: 7917210
[TBL] [Abstract][Full Text] [Related]
14. Interstitial wires releasing diffusing alpha emitters combined with chemotherapy improved local tumor control and survival in squamous cell carcinoma-bearing mice.
Cooks T; Arazi L; Efrati M; Schmidt M; Marshak G; Kelson I; Keisari Y
Cancer; 2009 Apr; 115(8):1791-801. PubMed ID: 19197995
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of silencing hTERT gene by short hairpin RNA on growth of human laryngeal squamous cell carcinoma xenograft in nude mice].
Liu D; Tao ZZ; Xiao BK; Chen SM; Chi HM
Ai Zheng; 2006 Jan; 25(1):11-6. PubMed ID: 16405742
[TBL] [Abstract][Full Text] [Related]
16. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
17. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
18. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec).
Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE
Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359
[TBL] [Abstract][Full Text] [Related]
19. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
Cheung NK; Modak S
Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
[TBL] [Abstract][Full Text] [Related]
20. Marked inhibition of growth and invasive parameters of head and neck squamous carcinoma FaDu by a nutrient mixture.
Roomi MW; Roomi NW; Kalinovsky T; Rath M; Niedzwiecki A
Integr Cancer Ther; 2009 Jun; 8(2):168-76. PubMed ID: 19679626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
